NPS Intelligence (beta)

Disclosed NPS & retention by vertical

Verticals  /  Pharma, medtech & health distribution  /  MiMedx Group, Inc.

MiMedx Group, Inc.

Pharma, medtech & health distributionMedical Device CompanyMDXG
mimedx.com ↗
—
Latest disclosed NPS
no score published
5
NPS entries
0 with a number
2024–25
Years covered
5 entries in all

In their words

“We believe our commitment to this approach will lead to enhanced customer relationships, improved Net Promoter Scores, higher margins and ultimately an increase in the average lifetime value of a customer.”
— Joseph Capper, Chief Executive Officer, MiMedx Group, Inc. · Earnings call, Q3 2025 · 29 Oct 2025
“We believe our commitment to this approach will lead to enhanced customer relationships, improved Net Promoter scores, higher margins and ultimately an increase in the average lifetime value of customer.”
— Joseph H. Capper, Chief Executive Officer, MiMedx Group, Inc. · Earnings call, Q2 2025 · 30 Jul 2025
“Our commitment to this approach will lead to enhanced customer relationships, improved Net Promoter Scores, higher margins and ultimately, an increase in the average lifetime value of a customer.”
— Joe Capper, Chief Executive Officer, MiMedx Group, Inc. · Earnings call, Q3 2024 · 30 Oct 2024

NPS disclosures (5)

Search the database →

29 Oct 2025
NPSProgram

We believe our commitment to this approach will lead to enhanced customer relationships, improved Net Promoter Scores, higher margins and ultimately an increase in the average lifetime value of a customer.

— Joseph Capper, Chief Executive Officer, MiMedx Group, Inc. · Earnings call, Q3 2025 · 29 Oct 2025
Earnings call, Q3 2025 ↗
30 Jul 2025
NPSProgram

We believe our commitment to this approach will lead to enhanced customer relationships, improved Net Promoter scores, higher margins and ultimately an increase in the average lifetime value of customer.

— Joseph H. Capper, Chief Executive Officer, MiMedx Group, Inc. · Earnings call, Q2 2025 · 30 Jul 2025
Earnings call, Q2 2025 ↗
30 Apr 2025
NPSProgram

As we introduce additional programs, we plan to measure our efforts through improved net promoter scores, higher margins, and ultimately, an increase in the average lifetime value of a customer.

— MiMedx Group, Inc. · SEC proxy statement · filed 30 Apr 2025
SEC proxy statement ↗
26 Feb 2025
NPSProgram

Develop and deploy tools aimed at improving customer relationships, our net promoter score and ultimately increase the lifetime value of each customer 1 2 3New for 2025 Capitalize on Opportunity with Pending LCDs In light of maturing reimbursement…

— MiMedx Group, Inc. · SEC 8-K filing · filed 26 Feb 2025
SEC 8-K filing ↗
30 Oct 2024
NPSProgram

Our commitment to this approach will lead to enhanced customer relationships, improved Net Promoter Scores, higher margins and ultimately, an increase in the average lifetime value of a customer.

— Joe Capper, Chief Executive Officer, MiMedx Group, Inc. · Earnings call, Q3 2024 · 30 Oct 2024
Earnings call, Q3 2024 ↗

Retention disclosures (0)

Open in the retention database →

No retention figures yet.

Lighthouse companies in Pharma, medtech & health distribution

The whole vertical →

About these figures

Every figure here was publicly disclosed by the named company: press releases, annual reports, SEC filings, earnings calls and news coverage. Companies tend to publish their NPS when it is good, so these numbers run higher than a true industry average: read them as what leading companies in this vertical say publicly, not as an industry benchmark.

NPS runs from −100 to +100. Retention figures are reported as the company defines them (net revenue retention, gross revenue retention, customer retention rate, churn). Every entry links to its source in the full database.